Another study on bone marrow mesenchymal stem cells from AIS patients supports this conclusion and identifies a key gene, SPRY4, which is significantly under-expressed in AIS bone marrow mesenchymal stem cells. The gene discussed is SPRY4; the disease is androgen insensitivity syndrome.